Similarly, Western blotting revealed very high expression of SOX2 in freshly derived glioma stem cell (GSC) cultures from human patients and in U251MG and U373MG cell lines, while A172, T98G and U87MG expressed low levels (Figure 1B,C). The gene discussed is SOX2; the disease is central nervous system cancer.